FR2117727A1 - Sodium naringine - for increasing capillary resistance and impermeability - Google Patents

Sodium naringine - for increasing capillary resistance and impermeability

Info

Publication number
FR2117727A1
FR2117727A1 FR7044631A FR7044631A FR2117727A1 FR 2117727 A1 FR2117727 A1 FR 2117727A1 FR 7044631 A FR7044631 A FR 7044631A FR 7044631 A FR7044631 A FR 7044631A FR 2117727 A1 FR2117727 A1 FR 2117727A1
Authority
FR
France
Prior art keywords
sodium
naringine
impermeability
capillary resistance
increasing capillary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7044631A
Other languages
French (fr)
Other versions
FR2117727B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROSENBERG EDY FR
Original Assignee
ROSENBERG EDY FR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROSENBERG EDY FR filed Critical ROSENBERG EDY FR
Priority to FR7044631A priority Critical patent/FR2117727A1/en
Publication of FR2117727A1 publication Critical patent/FR2117727A1/en
Application granted granted Critical
Publication of FR2117727B1 publication Critical patent/FR2117727B1/fr
Priority to FR7815186A priority patent/FR2426698A2/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
    • D06M13/46—Compounds containing quaternary nitrogen atoms
    • D06M13/463—Compounds containing quaternary nitrogen atoms derived from monoamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Textile Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The sodium deriv. of narangine of formula: increases capillary resistance and the impermeability of blood vessels. Useful in treating retinopathy, retinal haemorrhage, capillary permeability and disorders of the venous system. Prepd. by treating naringine with sodium ethoxide in ethanol.
FR7044631A 1970-12-09 1970-12-09 Sodium naringine - for increasing capillary resistance and impermeability Granted FR2117727A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7044631A FR2117727A1 (en) 1970-12-09 1970-12-09 Sodium naringine - for increasing capillary resistance and impermeability
FR7815186A FR2426698A2 (en) 1970-12-09 1978-05-23 Sodium salt of naringin prepn. - from naringin and sodium hydroxide in alcohol, used for treating circulatory and ophthalmic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7044631A FR2117727A1 (en) 1970-12-09 1970-12-09 Sodium naringine - for increasing capillary resistance and impermeability

Publications (2)

Publication Number Publication Date
FR2117727A1 true FR2117727A1 (en) 1972-07-28
FR2117727B1 FR2117727B1 (en) 1975-01-10

Family

ID=9065600

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7044631A Granted FR2117727A1 (en) 1970-12-09 1970-12-09 Sodium naringine - for increasing capillary resistance and impermeability

Country Status (1)

Country Link
FR (1) FR2117727A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027623A1 (en) * 1979-10-20 1981-04-29 Henkel Kommanditgesellschaft auf Aktien Composition for the control of suckling mastitis and pyogenes mastitis in cattle
EP0198965A1 (en) * 1984-01-10 1986-10-29 Lamorna Investments Proprietary Limited Benzo-pyrones as a treatment for exudative or disciform maculopathy
FR2633182A1 (en) * 1988-06-23 1989-12-29 Beljanski Mirko ANTI-CANCER PHARMACEUTICAL COMPOSITION AND METHOD OF USING THE INVENTION

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027623A1 (en) * 1979-10-20 1981-04-29 Henkel Kommanditgesellschaft auf Aktien Composition for the control of suckling mastitis and pyogenes mastitis in cattle
EP0198965A1 (en) * 1984-01-10 1986-10-29 Lamorna Investments Proprietary Limited Benzo-pyrones as a treatment for exudative or disciform maculopathy
FR2633182A1 (en) * 1988-06-23 1989-12-29 Beljanski Mirko ANTI-CANCER PHARMACEUTICAL COMPOSITION AND METHOD OF USING THE INVENTION
US5145839A (en) * 1988-06-23 1992-09-08 Mirko Beljanski Pharmaceutical composition and method of use

Also Published As

Publication number Publication date
FR2117727B1 (en) 1975-01-10

Similar Documents

Publication Publication Date Title
DK134051B (en) Means to induce a physiological cold effect on the skin or mucous membranes of the human body.
ES449663A1 (en) Peristaltic pumps
FI48593C (en) Process for the preparation of blood glucose lowering bornylene and nor-bornylene / 2,3-d / -N- (p-tolylsulfonylcarboxamino) -oxazolidinones.
FR2117727A1 (en) Sodium naringine - for increasing capillary resistance and impermeability
AR192517A1 (en) HEART VALVE OCCLUSOR MEMBER
DK107182C (en) Process for the preparation of an oral, pharmaceutical magnesium hydroxide preparation in the form of an aqueous suspension with antacid and laxative properties.
FR2134292A1 (en) Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
DK135785B (en) Trousers with adjustable waist.
NL171326B (en) ELECTRODE SYSTEM, ESPECIALLY FOR MEDICAL INTERNAL APPLICATION.
JPS5283911A (en) Fat emulsion for intravenous injection
Breed et al. " Touch me, like me": Artifact?
NL7503964A (en) ESTABLISHMENT AND METHOD FOR THE ELECTRO-THERAPEUTIC, ESPECIALLY CARCINOMA TREATMENT OF PATIENTS.
SU567887A1 (en) Method of regulating self-acting valves
FR2426698A2 (en) Sodium salt of naringin prepn. - from naringin and sodium hydroxide in alcohol, used for treating circulatory and ophthalmic disorders
DK122338B (en) Diaphragm valve with pressure body.
IT1030012B (en) PROCESS AND EVAPORATION DEVICE PARTICULARLY FOR THE CONCENTRATION OF JUICES, MUST, SAUCES AND SIMILAR
ZA723300B (en) Aqueous emulsion of vinyl acetate interpolymer,resorcinol
ES416766A1 (en) A procedure for the preparation of (3-trifluormethylphenoxy) - (4-chlorophenyl) acetate of 2-acetamidoetilo. (Machine-translation by Google Translate, not legally binding)
FR2092780A2 (en) 2-oxa-3-oxo-17-beta undecanoyloxy estra-4,9,11-triene - - long acting anabolic agent
ES164161U (en) A perfected hanger. (Machine-translation by Google Translate, not legally binding)
CH533990A (en) Pressure infusion or transfusion device
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
GB1237972A (en)
CA982047A (en) Control of slime in aqueous liquids with 2,2-dibromoacetophenone
DK112212B (en) Control valve with displacement body.

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property